Aehr Test Systems Stock 12‑Month Price Target Cut to $127, Implies 95% Upside

What happened

Aehr Test Systems’ average 12-month price target fell from $127.83 to $127, based on estimates from five analysts. The revised target implies approximately 95% upside from the Nov. 3 closing price. Six analysts covering the stock all rated it Buy, with no Hold or Sell ratings.

Confirmed

Global impact / market context

The target reduction signals that analysts slightly lowered their average valuation estimate, but the stated upside remains substantial relative to the Nov. 3 closing price. If investors use these forecasts to guide decisions, the all-Buy ratings could support interest in the stock, though targets are not guaranteed outcomes.

Analyst inference

The article reports analyst forecasts, not a company announcement or evidence of future business results. The $127 average target is based on five analysts, while the Buy consensus covers six; that difference means the rating count and target estimate do not represent identical analyst groups.

Confirmed

What to watch

1. Watch for later target updates from analysts, since a rising or falling average would change the reported gap between the forecast and the share price. Analyst inference
2. Check whether the six-analyst Buy consensus changes, especially if any covering analyst shifts to Hold or Sell or new analysts begin coverage. Analyst inference
3. Compare future reported company results with the assumptions behind analyst forecasts; the article gives no business performance details that explain the target or implied upside. Analyst inference

Evidence

• Original source link unavailable